Comparisons of health status scores with MRC grades in COPD: Implications for the GOLD 2011 classification

European Respiratory Journal

Volumn 42, Issue 3, 2013, Pages 647-654

  Jones, Paul W ^a   Adamek, Lukasz ^b   Nadeau, Gilbert ^b   Banik, Norbert ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST SCORE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MEDICAL RESEARCH COUNCIL; MEDICAL SOCIETY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84883547779     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00125612     Document Type: Article

References (20)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.com/guidelines-global-strategy-for-diagnosis-management.html Date last accessed: July 2012. Date last updated: February 2013.
2. The Global Initiative for Chronic Obstructive Lung disease (GOLD). 2010 Update: GOLD Report, Global Strategy for the Diagnosis, Management and Prevention of COPD. www.goldcopd.com.
3. Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122-135.
4. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
5. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38: 29-35.
6. Fletcher CM. The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med 1952; 45: 577-584.
7. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnoea. Chest 1988; 93: 580-586.
8. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586. (Pubitemid 29296676)
9. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011; 1: 57-66.
10. Meguro M, Barley EA, Spencer S, et al. Development and validation of an improved, COPD specific version of the St George Respiratory Questionnaire. Chest 2007; 132: 456-463. (Pubitemid 47282376)
11. Ware JE, Kosinski M, Keller SD. A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233. (Pubitemid 126433231)
12. Webster K, Odom L, Peterman A, et al. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version 4 of the core questionnaire. Qual Life Res 1999; 8: 604.
13. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404. (Pubitemid 34256951)
14. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences. The FACIT experience. Eval Health Prof 2005; 28: 172-191. (Pubitemid 40628906)
15. Kontodimopoulos N, Pappa E, Niakas D, et al. Validity of SF-12 summary scores in a Greek general population. Health Qual Life Outcomes 2007; 5: 55.
16. Ferrer M, Villasante C, Alonso J, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J. 2002; 19: 405-413. (Pubitemid 34256952)
17. Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-868.
18. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
19. 2-agonist, in subjects with COPD. Chest 2011; 140: 68-75.
20. Jones P, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med 2011; 11: 42.